Live feed08:00:00·33dPRReleasevia QuantisnowFortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B FinancingByQuantisnow·Wall Street's wire, on your screen.FBIO· Fortress Biotech Inc.Health Care